Anti-transcription intermediary factor 1-γ neuromyositis: A case report

被引：0
|
作者：
Chuo, Hui-En [1 ]
Li, Hsiao-Yu [1 ]
Wang, Wen-Hsiu [2 ,3 ,4 ]
Wu, Yu-Hung [1 ,4 ]
机构：
[1] MacKay Mem Hosp, Dept Dermatol, 92 Sec 2,Zhongshan North Rd, Taipei 10449, Taiwan
[2] MacKay Mem Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taipei, Taiwan
[3] MacKay Jr Coll Med Nursing & Management, Dept Nursing, New Taipei, Taiwan
[4] MacKay Med Coll, Dept Med, New Taipei, Taiwan
来源：
DERMATOLOGICA SINICA | 2023年 / 41卷 / 01期
关键词：
DERMATOMYOSITIS;
D O I：
10.4103/ds.DS-D-22-00078
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [1] Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ antibody
    Mizumaki, Kie
    Makino, Satoshi
    Ikawa, Yuka
    Maeda, Shintaro
    Horii, Motoki
    Fushida, Natsumi
    Hamaguchi, Yasuhito
    Nohara, Takahiro
    Izumi, Koji
    Matsushita, Takashi
    JOURNAL OF DERMATOLOGY, 2022, 49 (09): : E311 - E312
  • [2] A case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-α antibody showing negative anti-TIF1-γ ELISA results: Comment on "Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ antibody"
    Koizumi, Haruka
    Muro, Yoshinao
    Imai, Satoko
    Yamashita, Yuta
    Ogawa-Momohara, Mariko
    Takeichi, Takuya
    Murakami, Megumi
    Mitsuma, Teruyuki
    Akiyama, Masashi
    JOURNAL OF DERMATOLOGY, 2023, 50 (01): : E39 - E40
  • [3] Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
    Zhang, Suo
    Chen, Yu-Lan
    Liu, Cui-Lian
    Xie, Jing-Yi
    Sun, Bao-Dong
    Liu, Dong-Zhou
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Janus kinase inhibitor for anti-transcription intermediary factor 1-γ positive cancer-associated dermatomyositis
    Wu, Wanlong
    Chen, Jinju
    Zhu, Linling
    Sha, Yaping
    Wang, Kaiwen
    Zhao, Jiangfeng
    Ye, Chunhua
    Ye, Shuang
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (02) : 285 - 287
  • [5] Hallux patch during anti-transcription intermediary factor-1γ dermatomyositis
    Kluger, Nicolas
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (10) : 1246 - 1247
  • [6] Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation
    Aggarwal, Rohit
    Oddis, Chester V.
    Goudeau, Danielle
    Fertig, Noreen
    Metes, Ilinca
    Stephens, Chad
    Qi, Zengbiao
    Koontz, Diane
    Levesque, Marc C.
    RHEUMATOLOGY, 2014, 53 (03) : 433 - 437
  • [7] Anti-transcription Intermediary Factor1γ-antibody-positive Dermatomyositis Complicated by Dysphagia
    Kurushima, Shota
    Horai, Yoshiro
    Umeda, Masataka
    Kawakami, Atsushi
    INTERNAL MEDICINE, 2017, 56 (21) : 2965 - 2966
  • [8] Strong correlation between cancer progression and anti-transcription intermediary factor 1γ antibodies in dermatomyositis patients
    Ogawa-Momohara, M.
    Muro, Y.
    Mitsuma, T.
    Katayama, M.
    Yanaba, K.
    Nara, M.
    Kakeda, M.
    Kono, M.
    Akiyama, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : 990 - 995
  • [9] Characteristics of Anti-Transcription Intermediary Factor 1-gamma Autoantibody Positive Dermatomyositis Patients in Singapore
    Chua, Choon Guan
    Low, Jia Zhen
    Manghani, Mona
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [10] Association of Anti-Transcription Intermediary Factor 1γ Antibodies With Paraneoplastic Rheumatic Syndromes Other Than Dermatomyositis
    Venalis, Paulius
    Selickaja, Sandra
    Lundberg, Karin
    Rugiene, Rita
    Lundberg, Ingrid E.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (04) : 648 - 651
12345